The most significant predictors of PBC disease recurrence and outcome, include tumor size, histological grade, lymph node involvement, expression of estrogen and/or progesterone receptors, human epidermal growth factor receptor 2 expression and the presence of circulating tumor cells (8,9). Here, ERBB2 is linked to neoplasm.